Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07043426 · ClinicalTrials.gov registry record · NA

Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community Partnerships

A NA study of Diabetes Mellitus, Type 2, sponsored by Boston Medical Center.

Recruiting
Registry status
NA
Development phase
900
Enrollment target
1
Study location

NCT07043426 is a NA study of Diabetes Mellitus, Type 2 that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 900 participants, below the 4,483-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07043426, a NA study of Diabetes Mellitus, Type 2, is actively recruiting participants, sponsored by Boston Medical Center.

RECRUITING
Registry status
NA
Development phase
900 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to develop, implement, and evaluate a patient-centered triage and referral model designed to improve health outcomes for individuals with uncontrolled type 2 diabetes mellitus (T2DM) and unmet health-related social needs. The intervention builds on the existing THRIVE infrastructure at Boston Medical Center (BMC), which includes screening for social needs and a resource referral guide. It integrates medical and social care by embedding a data-driven triage tool within the EPIC electronic health record system, engaging community health workers trained in population health, and initiating closed-loop EPIC integrated referrals to community-based organizations. This study will use a hybrid type 3 effectiveness-implementation trial design to evaluate the implementation of the THRIVE-DM intervention at the clinic level. Preliminary effectiveness will be assessed by comparing THRIVE-DM to usual care in its ability to increase patient connections to community-based organizations and improve clinical outcomes. Using a stratified randomization approach, the investigators will compare referral closure rates, receipt of social services, hemoglobin A1C levels, and patterns of health service utilization between patients enrolled in THRIVE-DM and those receiving standard care

Conditions Studied

Interventions

  • OTHER Standard of care
  • OTHER THRIVE-DM

Study Locations (1)

Massachusetts

  • Boston Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2025-12-26
Est. Completion 2027-04
Phase NA

Sponsor

Boston Medical Center

253 total trials

What the Registry Record Tells You About NCT07043426

The ClinicalTrials.gov registry entry for NCT07043426 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,483-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (80% lower). The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.

NCT07043426 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07043426 about?

NCT07043426 is a clinical study titled "Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community Partnerships". The goal of this study is to develop, implement, and evaluate a patient-centered triage and referral model designed to improve health outcomes for individuals with uncontrolled type 2 diabetes mellitus (T2DM) and unmet health-related social needs. The intervention builds on the existing THRIVE infra...

What is the current status of trial NCT07043426?

This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2025-12-26. Estimated completion is 2027-04.

What conditions does trial NCT07043426 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT07043426?

The interventions under investigation include: Standard of care (OTHER), THRIVE-DM (OTHER).

Who is sponsoring clinical trial NCT07043426?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07043426 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.